Published in Rev Epidemiol Sante Publique on January 01, 1977
In vivo standardization of cutaneous bactericidal activity of antiseptics by using monoxenic hairless mice. Appl Environ Microbiol (1989) 0.75
A simple method for the isolation of chromosomal DNA from gram positive or acid-fast bacteria. Nucleic Acids Res (1991) 2.82
Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple's disease bacillus. Int J Syst Evol Microbiol (2001) 2.37
Massilia timonae gen. nov., sp. nov., isolated from blood of an immunocompromised patient with cerebellar lesions. J Clin Microbiol (1998) 2.11
An ethical approach to screening for human immunodeficiency virus. Eur J Med (1992) 2.02
Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med (1995) 2.01
Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med (1996) 1.46
Real-time PCR for universal antibiotic susceptibility testing. J Antimicrob Chemother (2004) 1.19
[Statistical study of the SIRSCAN computerised camera]. Pathol Biol (Paris) (1997) 1.15
Serological response of tuberculosis patients to antigen 60 of BCG. Eur J Epidemiol (1992) 1.13
[Value of systematic preventive antibiotherapy in cardiac pacemaker implantation]. Ann Cardiol Angeiol (Paris) (1991) 1.08
Value of ELISA using A60 antigen in the diagnosis of active pulmonary tuberculosis. Am Rev Respir Dis (1990) 1.02
Correlation between serum doxycycline concentrations and serologic evolution in patients with Coxiella burnetii endocarditis. J Infect Dis (2003) 1.00
Isolation of mycobacteria from clinical samples using the centrifugation-shell vial technique. Eur J Clin Microbiol Infect Dis (2000) 0.98
Heat and moisture exchangers and vaporizing humidifiers in the intensive care unit. Chest (1990) 0.95
Pharmacokinetics and tissue penetration of a single dose of ornidazole (1,000 milligrams intravenously) for antibiotic prophylaxis in colorectal surgery. Antimicrob Agents Chemother (1990) 0.91
Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium. J Antimicrob Chemother (2005) 0.89
In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex. J Antimicrob Chemother (1993) 0.88
Pharmacokinetics and tissue penetration of a single 1,000-milligram, intravenous dose of metronidazole for antibiotic prophylaxis of colorectal surgery. Antimicrob Agents Chemother (1991) 0.88
Tobramycin dosing in mechanically ventilated patients. Inaccuracy of a 'rule of thumb'. J Antimicrob Chemother (1988) 0.88
Ofloxacin penetration into cerebrospinal fluid. J Antimicrob Chemother (1988) 0.88
French multicenter study involving eight test sites for radiometric determination of activities of 10 antimicrobial agents against Mycobacterium avium complex. Antimicrob Agents Chemother (1995) 0.88
Multicentric genetic study of Candida albicans isolates from non-neutropenic patients using MLEE typing: population structure and mode of reproduction. Mycoses (2000) 0.87
Comparison of concentrations of sulbactam-ampicillin administered by bolus injections or bolus plus continuous infusion in tissues of patients undergoing colorectal surgery. Antimicrob Agents Chemother (1998) 0.85
Streptococcus lactis septicemia in a patient with chronic lymphocytic leukemia. Am J Hematol (1995) 0.85
[In vitro evaluation of the sensitivity to fluconazole of different species of yeasts isolated in pathology]. Pathol Biol (Paris) (1992) 0.85
Penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia. Antimicrob Agents Chemother (1994) 0.83
Comparison of two methods of bacteriologic sampling of the lower respiratory tract: a study in ventilated patients with nosocomial bronchopneumonia. Crit Care Med (1989) 0.83
Penetration of vancomycin into mediastinal and cardiac tissues in humans. Antimicrob Agents Chemother (1994) 0.82
[Bacteriostatic and bactericidal study of rifabutine and clofazimine in combination against Mycobacterium avium-intracellulare and Mycobacterium xenopi]. Pathol Biol (Paris) (1989) 0.81
[Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum]. Pathol Biol (Paris) (1991) 0.80
Comparison of concentrations of two doses of clavulanic acid (200 and 400 milligrams) administered with amoxicillin (2,000 milligrams) in tissues of patients undergoing colorectal surgery. Antimicrob Agents Chemother (1995) 0.80
Ethical problems raised by anti-HIV vaccination. Eur J Epidemiol (1991) 0.79
The ethical approach to AIDS: a bibliographical review. J Med Ethics (1990) 0.79
AIDS, a social dilemma: detection of seropositives. Eur J Epidemiol (1991) 0.79
[A simplified formula to explain the sensitivity of viral reproduction to temperature]. Ann Inst Pasteur (Paris) (1967) 0.79
[Diffusion of ciprofloxacin into bronchial secretions in mechanically ventilated patients]. Pathol Biol (Paris) (1991) 0.78
Multilocus enzyme electrophoresis analysis of Candida albicans isolates from three intensive care units. An epidemiological study. Mycoses (1997) 0.78
[Use of the Bactec TB 460 method for the bacteriological diagnosis of tuberculosis. Results of a multicenter study]. Pathol Biol (Paris) (1995) 0.78
[Perioperative remote infections in neurosurgery. Role of antibiotic prophylaxis]. Presse Med (1992) 0.78
Isolation of blood-borne Mycobacterium avium by using the nonradioactive BACTEC 9000 MB system and comparison with a solid-culture system. J Clin Microbiol (1998) 0.77
[Evaluation of ciprofloxacin versus amoxicillin + clavulanic acid or erythromycin for the empiric treatment of community-acquired pneumonia]. Pathol Biol (Paris) (1991) 0.77
[Mycological monitoring of Candida albicans infections in various hospital care units. Molecular typing of isolated strains and epidemiological survey]. Pathol Biol (Paris) (1996) 0.76
Evaluation of internal transcribed spacer region of ribosomal DNA sequence analysis for molecular characterization of Candida albicans and Candida dubliniensis isolates from HIV-infected patients. Med Mycol (2002) 0.76
In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study. Int J Antimicrob Agents (2005) 0.76
[Sensitivity of 7 mycobacterial species to new quinolones]. Pathol Biol (Paris) (1988) 0.76
Concentrations of ceftriaxone (1,000 milligrams intravenously) in abdominal tissues during open prostatectomy. Antimicrob Agents Chemother (1996) 0.75
[Value of the aminoglycoside-fosfomycin combination. Apropos of a case of bacterial endocarditis]. Pathol Biol (Paris) (1985) 0.75
[Activity of azithromycin and roxithromycin alone or in combination against Mycobacterium avium and Mycobacterium xenopi]. Pathol Biol (Paris) (1990) 0.75
Prevention of HIV infection by transfusion: comparative analysis of systems adopted in developed countries. AIDS Public Policy J (1991) 0.75
[Prolonged controlled ventilation. The Pall-Ultripor filter or moisturizing-heating devices?]. Presse Med (1990) 0.75
[Haemophilus influenzae in respiratory pathology]. Mars Med (1972) 0.75
[Induction of a viral development in cells originating from human primary malignant adenopathies]. C R Acad Sci Hebd Seances Acad Sci D (1972) 0.75
AIDS: the rights and duties of health-care providers. AIDS Public Policy J (1991) 0.75
Ethics and AIDS: the protection of society versus the protection of individual rights. AIDS Public Policy J (1991) 0.75
Pharmacokinetics of azlocillin in bronchial secretions. Chemioterapia (1987) 0.75
[Antibiotherapy in gangrene of the perineum]. Presse Med (1988) 0.75
[Chemoprevention with intravenous doxycycline in 40 cases of colonic esophagoplasty]. Presse Med (1983) 0.75
[Coxsackievirus maturation. I. Study of physico-chemical factors]. Ann Inst Pasteur (Paris) (1971) 0.75
[Adjustment of tobramycin doses. Lack of reliability of a simple nomogram]. Presse Med (1988) 0.75
[Effect of infra and supra-optimal temperatures on the development of Coxsackie virus]. Ann Inst Pasteur (Paris) (1969) 0.75
[Tissue penetration of single-dose cefotetan used for antibiotic prophylaxis in colorectal surgery]. Pathol Biol (Paris) (1990) 0.75
[Post-antibiotic effect of imipenem, amikacin and ciprofloxacin against various strains of Serratia marcescens]. Pathol Biol (Paris) (1990) 0.75
[Not Available]. Kos (1992) 0.75
[New cold variant of Coxsackie virus B5. 3. Protective capacity and capacity for inducing interferon]. C R Seances Soc Biol Fil (1970) 0.75
[Eosinophilic leukemia or disseminated eosinophilic collagen disease? (apropos of severe nonparasitic eosinophilia)]. Mars Med (1970) 0.75
[The maturation of Coxsackie virus. II. Intervention of a thermorestrictive nucleasic rupture]. Ann Inst Pasteur (Paris) (1972) 0.75
[Antibioprophylaxis with cefamandole in neurosurgery]. Presse Med (1989) 0.75
AIDS: the rights of patients. AIDS Public Policy J (1991) 0.75
[Treatment of nosocomial pneumopathies caused by Pseudomonas aeruginosa with ceftazidime. 50 cases in pulmonary resuscitation]. Presse Med (1988) 0.75
[Identification of Mycobacterium tuberculosis and Mycobacterium avium by non-radioactive probes: evaluation of the Snap Syngene system]. Ann Biol Clin (Paris) (1992) 0.75
A rapid high-performance liquid chromatography method for determining beta-lactam antibiotics in biological fluids and tissues. Chemioterapia (1987) 0.75
[Measure of the activity of a quaternary aldehyde-ammonia complex against reference bacteria strains and 50 hospital strains]. Pathol Biol (Paris) (1985) 0.75
AIDS: a storm threatening medical confidentiality. AIDS Public Policy J (1991) 0.75
[In vitro maturation of the final precursor of Coxsackie virus]. C R Acad Sci Hebd Seances Acad Sci D (1974) 0.75
[Use of azlocillin in the treatment of Pseudomonas bronchopulmonary infections]. Presse Med (1984) 0.75
[Diagnosis of primary malignant adenopathies]. Mars Med (1970) 0.75
Phagocyte-pathogen in the infected host. Crit Care Med (1989) 0.75
[Original properties common to picornaviruses induced in cell cultures from human malignant primary adenopathies]. C R Acad Sci Hebd Seances Acad Sci D (1972) 0.75
[Variations in microbial pollution of the air at the level of the "towers" of modern urban blocks in Marseilles]. Bull Acad Natl Med (1965) 0.75
[New cold Coxsackie virus B 5 variant. IV. Evolution of interferon quantities in young mice as a function of time]. C R Seances Soc Biol Fil (1971) 0.75
[Pleuro-pulmonary infections with anaerobic germs (author's transl)]. Poumon Coeur (1981) 0.75
[Activity of antibiotics against pigmented and unpigmented variants of Mycobacterium avium-intracellulare]. Pathol Biol (Paris) (1991) 0.75
[Application of the diagnostic ability coefficient to the comparison of 3 identification miniaturized systems for identifying anaerobic bacteria]. Pathol Biol (Paris) (1988) 0.75
[Clinical and pharmacokinetic study of ceftriaxone in severe infections in adults in intensive care]. Pathol Biol (Paris) (1986) 0.75
[Limiting reaction of virus yield at infra-optimal temperature]. Ann Inst Pasteur (Paris) (1969) 0.75
[Bacteriological diagnosis of bronchopneumopathies in patients under ventilation. Is distal brushing under fiber optics interesting?]. Presse Med (1987) 0.75
[Value of the germ-carrier method for testing of the activity of disinfectants against mycobacteria strains]. Pathol Biol (Paris) (1987) 0.75
[Antibacterial kinetics of fosfomycin (author's transl)]. Ann Biol Clin (Paris) (1979) 0.75
Detection and identification of Mycobacterium tuberculosis, M. bovis/BCG, and M. avium by two-step polymerase chain reaction. Comparison with ELISA using A60 antigen. Microbiologica (1992) 0.75
[Autoimmune hemolytic anemia associated with other autoimmune diseases]. Mars Med (1971) 0.75